TNF and COVID-19: A high incidence of lymphopenia, ranging from 67–75%, has been consistently reported among COVID-19 patients who have a severe illness; it may correlate with an increased quantity of cytokines such as IL-6, IL-10 or TNF (tumor necrosis factor) [82,83].